نتائج البحث - B Osterwalder

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    Oral tramadol, a μ-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain

    Oral tramadol, a μ-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain حسب Clive H. Wilder‐Smith, J. Schimke, B Osterwalder, Hans-Jörg Senn

    منشور في 1994
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil

    Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil حسب Eric Van Cutsem, Paulo M. Hoff, JL Blum, Maryline Abt, B Osterwalder

    منشور في 2002
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Translational Medicine Guide transforms drug development processes: the recent Merck experience

    Translational Medicine Guide transforms drug development processes: the recent Merck experience حسب Hugues Dolgos, Mark Trusheim, Dietmar Groß, Joern-Peter Halle, Janet Ogden, B Osterwalder, Ewen Sedman, Luciano Rossetti

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.

    Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. حسب B Speck, Aloïs Gratwohl, C Nissen, U Leibundgut, D Ruggero, B Osterwalder, Haran Burri, P Cornu, M Jeannet

    منشور في 1981
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

    A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours حسب L. Pronk, P. Vasey, Alex Sparreboom, Bruno Reigner, André Planting, R J Gordon, B Osterwalder, Jaap Verweij, Chris Twelves

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

    Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients حسب Joanne L. Blum, V�ronique Dieras, Patricia Mucci Lo Russo, John Horton, Olga Rutman, Aman U. Buzdar, B Osterwalder

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia

    Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia حسب J Gmür, A. von Felten, B Osterwalder, Hanspeter Honegger, A. Hörmann, C. Sauter, K A Deubelbeiss, Willi Berchtold, M. N. Metaxas, G Scali, Frick Pg

    منشور في 1983
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

    Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line thera... حسب Joyce O’Shaughnessy, Joanne L. Blum, Vladimir Moiseyenko, Stephen E. Jones, David Miles, Diana Bell, R. Rosso, L. Mauriac, B Osterwalder, Hans Ulrich Burger, Siobhan Laws

    منشور في 2001
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

    Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines حسب Denis Talbot, Vladimir Moiseyenko, Simon Van Belle, S.M. O'Reilly, Emilio Alba, Stephen P. Ackland, Peter D. Eisenberg, David Melnychuk, Tadeusz Pieńkowski, H-U Burger, Siobhan Laws, B Osterwalder

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin

    First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin حسب Jim Cassidy, Chris Twelves, Eric Van Cutsem, Paulo M. Hoff, Emilio Bajetta, Michael Boyer, R. Bugat, Ulrich Bürger, A. Garin, Ullrich Graeven, J. McKendrick, Jean A. Maroun, John L. Marshall, B Osterwalder, G. Pérez-Manga, R. Rosso, P. Rougier, Richard L. Schilsky

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: